Corvus Pharmaceuticals shares rose 14% in after-market trading after the company said it would announce interim data from a Phase 1 clinical trial evaluating soquelitinib in patients with moderate to ...
The New York Stock Exchange will delist warrants of Pinstripes Holdings, citing abnormally low selling prices. Trading of the entertainment-dining company's warrants will be suspended immediately, the ...